Catalog No.
EVV03823
Expression system
Mammalian cells
Species
Influenza A virus (A/Utah/11/2023 (H1N1))
Protein length
Ala17-Ile530
Predicted molecular weight
65.10 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
WHO42457.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Hemagglutinin, Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, HA
Tuning the Aggregation of Plasmonic Probes to Shed Light on Diagnostic Strategies., PMID:40504768
Inhibition of Influenza Entry by Organosilicon Compounds., PMID:40492611
Label-Free Detection of Virus-Membrane Interactions Using Surface-Enhanced Infrared Absorption (SEIRA) Spectroscopy., PMID:40489072
Genetic diversity of H9N2 avian influenza viruses in poultry across China and implications for zoonotic transmission., PMID:40461649
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission., PMID:40434105
Phylogenetic Analysis and Spread of HPAI H5N1 in Middle Eastern Countries Based on Hemagglutinin and Neuraminidase Gene Sequences., PMID:40431745
A G219A hemagglutinin substitution increases pathogenicity and viral replication of Eurasian avian-like H1N1 swine influenza viruses., PMID:40408884
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo., PMID:40398322
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface., PMID:40391889
Shared host genetic landscape of respiratory viral infection., PMID:40372436
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Influenza virus: Genomic insights, evolution, and its clinical presentation., PMID:40345348
Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine., PMID:40328185
Unique phenomenon of H5 highly pathogenic avian influenza virus in China: co-circulation of Clade 2.3.4.4b H5N1 and H5N6 results in diversity of H5 Virus., PMID:40326336
Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models., PMID:40324597
Multiple antiviral mechanisms of Ephedrae Herba and Cinnamomi Cortex against influenza: inhibition of entry and replication., PMID:40304468
Molecular and In Vivo Characterization of the High Pathogenicity H7N6 Avian Influenza Virus That Emerged in South African Poultry in 2023., PMID:40303135
Effects of the Glycosylation of the HA Protein of H9N2 Subtype Avian Influenza Virus on the Pathogenicity in Mice and Antigenicity., PMID:40303068
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses., PMID:40301359
Influenza B viruses are more susceptible to high temperatures than influenza A viruses., PMID:40295766
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
The Ongoing Epidemics of Seasonal Influenza A(H3N2) in Hangzhou, China, and Its Viral Genetic Diversity., PMID:40284969
Comparative Mutational Analysis and the Glycosylation Patterns of a Peruvian Isolated Avian Influenza A Virus H5N1: Exploring Possible Viral Spillover Events Within One Health Approach., PMID:40284894
The bat influenza A virus subtype H18N11 induces nanoscale MHCII clustering upon host cell attachment., PMID:40280957
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies., PMID:40267182
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle., PMID:40263387
Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of hemagglutinin., PMID:40263249
Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data., PMID:40262547
Evolutionary dynamics and molecular epidemiology of H1N1 pandemic 2009 influenza A viruses across swine farms in Denmark., PMID:40235651
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors., PMID:40232794
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
Emergence of influenza A(H1N1)pdm09 6B.1A.5a.2a and 6B.1A.5a.2a.1 subclades leading to subtyping failure in a commercial molecular assay., PMID:40220733
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors., PMID:40207931
Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023., PMID:40205236
A paper-based loop-mediated isothermal amplification assay for highly pathogenic avian influenza., PMID:40204842
Isoxazole and Pyrazole Derivatives of 28-Oxo-Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin., PMID:40195084
De novo design and discovery of broad-spectrum affinity peptide ligands for influenza A vaccines., PMID:40194500
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains., PMID:40192841
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin., PMID:40192291
Machine learning methods for predicting human-adaptive influenza A virus reassortment based on intersegment constraint., PMID:40190733
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model., PMID:40176109
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
Tracking Seasonal Influenza Trends in South Tyrol During 2022/2023 Using Genomic Surveillance Data., PMID:40143444
For research use only. Not for human or drug use.
